Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.915 USD | -4.85% | -0.30% | -41.52% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.52% | 1.66B | |
+48.84% | 56.95B | |
+39.98% | 40.26B | |
-7.03% | 39.32B | |
-4.42% | 28.37B | |
+12.31% | 26.45B | |
-17.98% | 19.41B | |
+29.22% | 12.54B | |
+26.17% | 12.21B | |
-0.18% | 12.15B |
- Stock Market
- Equities
- NMRA Stock
- News Neumora Therapeutics, Inc.
- Neumora Therapeutics Starts Phase 1 Trial of NMRA-266 as Potential Treatment of Schizophrenia, Neuropsychiatric Disorders